Skip to content
Stop using now Drug recall · FDA · Published October 9, 2019

Ingenus Leucovorin Calcium Injection Recall: Particulate Matter Risk

Ingenus Pharmaceuticals recalls Leucovorin Calcium Injection vials with particulate matter risk. Affected lots expire April 2020 or later. Contact for return instructions.

🇺🇸 FDA recall #D-0146-2020DrugIngenus ›
Take action

Contact the company

Recalling firmIngenus Pharmaceuticals Llc4190 Millenia Blvd · Orlando, FL 32839-6408
✎ GovInfoNow plain-language explainer

Ingenus Pharmaceuticals is recalling Leucovorin Calcium Injection vials that may contain crystallized particles. This could cause serious harm if injected. Patients should stop using these vials immediately. Read more at govinfonow.com/recall/37863-ingenus-leucovorin-calcium-injection-recall-particulate-matter-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37863-ingenus-leucovorin-calcium-injection-recall-particulate-matter-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0146-2020

Cite this page

“Ingenus Leucovorin Calcium Injection Recall: Particulate Matter Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37863-ingenus-leucovorin-calcium-injection-recall-particulate-matter-risk. Based on FDA recall #D-0146-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0146-2020%22&limit=1).

Ingenus Pharmaceuticals Llc recalled Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 due to crystallization hazards. The Food and Drug Administration announced the Class II recall on Oct. 9, 2019.

How to tell if you have it

  • Brand: Ingenus
  • Product: Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only
  • Lot codes: 18048 Exp. 04/2020; 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020
  • Quantity: 16,485 vials

The hazard

The recall cites the presence of particulate matter identified as API crystallization. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Ingenus Pharmaceuticals Llc has four other recalls on record since June 8, 2018. Other recent recalls include an Ingenus Flunisolide Nasal Solution recall on Sept. 30, 2022, and an Ingenus Clobetasol Foam recall on Jan. 10, 2022. Similar product recalls include a Mallinckrodt Acthar Gel 5mL Vial recall on Aug. 6, 2026, and a Guardian Drug CAREone Calcium Antacid recall on May 28, 2026.

How to tell if you have this one

Check for vials labeled 'Leucovorin Calcium Injection, USP 500 mg/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50'. Lot numbers 18048, 18049 (expiring April 2020) or 18050 (May 2020) or 19036 (December 2020).

  • Brand
    Ingenus
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Vial Now

    Immediately discard the recalled vial if you have it.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Oct 9, 201912. FDA classified it Class II: Oct 17, 201923. Published in FDA’s Enforcement Report: Oct 23, 201934. FDA terminated the recall: Dec 1, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0146-2020 (October 9, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0146-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA